NCT07925463
Comparison of NMTCuff and Standard TOF in Gynecologic Oncology Surgery (NMTCUFF-TOF)
StatusRecruiting
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 1 word
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Time to Neuromuscular Recovery (TOF Ratio >= 0.90)
Timeframe: From the exact moment of Sugammadex administration up to endotracheal extubation (approximately 10 to 20 minutes).
Secondary (1)
Technical Feasibility and Signal Continuity Under Surgical Drapes
Arms and interventions
Simultaneous Dual NMT Cohort
A single cohort of patients where each patient receives two different neuromuscular transmission (NMT) monitoring methods simultaneously on opposite arms during elective laparoscopic gynecologic oncology surgery.
Other: Dual Neuromuscular Transmission Monitoring
Sites
1 site in 1 country
- Dr. Abdurrahman Yurtarslan Oncology Training and Research HospitalAnkara, Turkey (Türkiye)